Literature DB >> 7910180

Environmental sampling for aspergilli during building construction on a hospital site.

J M Goodley1, Y M Clayton, R J Hay.   

Abstract

During the course of extensive building activity at Guy's Hospital, London, air sampling was carried out weekly, for one year, to monitor the frequency of spores of Aspergillus spp. in both the hospital grounds and a number of defined ward areas. Nasal swabs were taken from patients on a selected ward to assess the nasal carriage of Aspergillus. The weather conditions were monitored at the time of sampling. The predominant species was Aspergillus fumigatus which occurred at a low frequency throughout the year, with little evidence of seasonal variation bar a peak in March. Few differences were found between internal and external spore counts. Localized building activity in a ward area and a laboratory area did not result in higher internal levels. Six percent of the nasal swabs were positive for A. fumigatus, though none of these patients became infected.

Entities:  

Mesh:

Year:  1994        PMID: 7910180     DOI: 10.1016/0195-6701(94)90076-0

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  22 in total

1.  Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation.

Authors:  Anil A Panackal; Hong Li; Dimitrios P Kontoyiannis; Motomi Mori; Cheryl A Perego; Michael Boeckh; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 2.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Andrew B Shreiner; Roderick A McDonald; John J Osterholzer; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

4.  Aspergillosis in Larus cachinnans micaellis: survey of eight cases.

Authors:  Simona Nardoni; Renato Ceccherelli; Giacomo Rossi; Francesca Mancianti
Journal:  Mycopathologia       Date:  2006-05       Impact factor: 2.574

5.  Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air.

Authors:  K Anderson; G Morris; H Kennedy; J Croall; J Michie; M D Richardson; B Gibson
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

6.  Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

Authors: 
Journal:  J Prev Med Hyg       Date:  2020-02-13

7.  Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging.

Authors:  Jennifer Poelmans; Amy Hillen; Liesbeth Vanherp; Kristof Govaerts; Johan Maertens; Tom Dresselaers; Uwe Himmelreich; Katrien Lagrou; Greetje Vande Velde
Journal:  Lab Invest       Date:  2016-03-28       Impact factor: 5.662

Review 8.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

9.  Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence.

Authors:  Ruchi Bhabhra; Michael D Miley; Eleftherios Mylonakis; Doug Boettner; Jarrod Fortwendel; John C Panepinto; Michael Postow; Judith C Rhodes; David S Askew
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  MDA5 Is an Essential Sensor of a Pathogen-Associated Molecular Pattern Associated with Vitality That Is Necessary for Host Resistance against Aspergillus fumigatus.

Authors:  Xi Wang; Alayna K Caffrey-Carr; Ko-Wei Liu; Vanessa Espinosa; Walburga Croteau; Sourabh Dhingra; Amariliz Rivera; Robert A Cramer; Joshua J Obar
Journal:  J Immunol       Date:  2020-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.